Amit Bar-Or
Amit Bar-Or
Verified email at upenn.edu
TitleCited byYear
B-cell depletion with rituximab in relapsing–remitting multiple sclerosis
SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ...
New England Journal of Medicine 358 (7), 676-688, 2008
18902008
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ...
New England Journal of Medicine 367 (12), 1098-1107, 2012
12162012
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
L Kappos, D Li, PA Calabresi, P O'Connor, A Bar-Or, F Barkhof, M Yin, ...
The Lancet 378 (9805), 1779-1787, 2011
6132011
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
M Duddy, M Niino, F Adatia, S Hebert, M Freedman, H Atkins, HJ Kim, ...
The Journal of Immunology 178 (10), 6092-6099, 2007
5162007
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
TA Barr, P Shen, S Brown, V Lampropoulou, T Roch, S Lawrie, B Fan, ...
Journal of Experimental Medicine 209 (5), 1001-1010, 2012
4162012
Rituximab in relapsing‐remitting multiple sclerosis: a 72‐week, open‐label, phase I trial
A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ...
Annals of neurology 63 (3), 395-400, 2008
4122008
Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions
B Banwell, A Ghezzi, A Bar-Or, Y Mikaeloff, M Tardieu
The Lancet Neurology 6 (10), 887-902, 2007
3952007
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses
PW O’connor, D Li, MS Freedman, A Bar-Or, GPA Rice, C Confavreux, ...
Neurology 66 (6), 894-900, 2006
3822006
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays
PJ Waters, A McKeon, MI Leite, S Rajasekharan, VA Lennon, A Villalobos, ...
Neurology 78 (9), 665-671, 2012
3762012
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
JM Burton, S Kimball, R Vieth, A Bar-Or, HM Dosch, R Cheung, D Gagne, ...
Neurology 74 (23), 1852-1859, 2010
3672010
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis
A Bar‐Or, RK Nuttall, M Duddy, A Alter, HJ Kim, I Ifergan, CJ Pennington, ...
Brain 126 (12), 2738-2749, 2003
3552003
Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease
A Monsonego, V Zota, A Karni, JI Krieger, A Bar-Or, G Bitan, AE Budson, ...
The Journal of clinical investigation 112 (3), 415-422, 2003
3352003
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?
A Bar‐Or, L Fawaz, B Fan, PJ Darlington, A Rieger, C Ghorayeb, ...
Annals of neurology 67 (4), 452-461, 2010
3282010
Distinct profiles of human B cell effector cytokines: a role in immune regulation?
ME Duddy, A Alter, A Bar-Or
The Journal of Immunology 172 (6), 3422-3427, 2004
3222004
Comparison of polarization properties of human adult microglia and blood‐derived macrophages
BA Durafourt, CS Moore, DA Zammit, TA Johnson, F Zaguia, MC Guiot, ...
Glia 60 (5), 717-727, 2012
3162012
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study
B Banwell, L Krupp, J Kennedy, R Tellier, S Tenembaum, J Ness, ...
The Lancet Neurology 6 (9), 773-781, 2007
3132007
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
M Mehling, V Brinkmann, J Antel, A Bar-Or, N Goebels, C Vedrine, ...
Neurology 71 (16), 1261-1267, 2008
2882008
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
KC O'Connor, KA McLaughlin, PL De Jager, T Chitnis, E Bettelli, C Xu, ...
Nature medicine 13 (2), 211, 2007
2622007
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study
B Banwell, A Bar-Or, DL Arnold, D Sadovnick, S Narayanan, M McGowan, ...
The Lancet Neurology 10 (5), 436-445, 2011
2612011
Incidence of acquired demyelination of the CNS in Canadian children
B Banwell, J Kennedy, D Sadovnick, DL Arnold, S Magalhaes, ...
Neurology 72 (3), 232-239, 2009
2512009
The system can't perform the operation now. Try again later.
Articles 1–20